BCAL Diagnostics Ltd
ASX:BDX

Watchlist Manager
BCAL Diagnostics Ltd Logo
BCAL Diagnostics Ltd
ASX:BDX
Watchlist
Price: 0.1 AUD -2.44%
Market Cap: 36.8m AUD

Wall Street
Price Targets

BDX Price Targets Summary
BCAL Diagnostics Ltd

There are no price targets for BDX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
BCAL Diagnostics Ltd Competitors:
Price Targets
ENTA
Enanta Pharmaceuticals Inc
18% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
63% Upside
ARX
Aroa Biosurgery Ltd
22% Upside
NRIX
Nurix Therapeutics Inc
47% Upside
CRSP
CRISPR Therapeutics AG
41% Upside
PBYI
Puma Biotechnology Inc
20% Downside
SLNO
Soleno Therapeutics Inc
136% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
8% Upside

Revenue
Forecast

Revenue Estimate
BCAL Diagnostics Ltd

For the last 6 years the compound annual growth rate for BCAL Diagnostics Ltd's revenue is 48%. The projected CAGR for the next 1 year is 367%.

48%
Past Growth
367%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
BCAL Diagnostics Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
BCAL Diagnostics Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BDX's stock price target?
Not Available

BDX doesn't have any price targets made by Wall Street professionals.

What is BCAL Diagnostics Ltd's Revenue forecast?
Projected CAGR
367%

For the last 6 years the compound annual growth rate for BCAL Diagnostics Ltd's revenue is 48%. The projected CAGR for the next 1 year is 367%.

Back to Top